62 results
Comparison of strategies for vascular ACCESS closure after transcatheter aortic valve implantation: the ACCESS-TAVI randomized trial
04 Nov 2024
The present study explores the alternative of 1 suture-based + 1 plug closure device vs. the conventional one, finding a superiority of this approach in achieving the full closure, hemostasis with a reduced incidence of complications.
Reviewer
Percutaneous edge-to-edge repair for tricuspid regurgitation: 3-year outcomes from the TRILUMINATE study
30 Oct 2024
In this analysis, the 3-year outcomes of the TRILUMINATE study are presented, evaluating the long-term effectiveness of the TriClip T-TEER system on TR reduction, right ventricular remodeling, quality of life, and heart failure symptoms.
Reviewer
Reviewer
Structural cardiac interventions in patients with heart failure
27 Aug 2024
The review aims to address the unmet needs in heart failure (HF) management, particularly in patients where structural heart disease coexists with HF and limits the effectiveness of guideline-directed medical therapy (GDMT).
Reviewer
Prognostic implications of residual tricuspid regurgitation grading after transcatheter tricuspid valve repair
18 Jun 2024
The take-home message for clinicians is that in the treatment of tricuspid regurgitation, the most frequent valvular disease alongside aortic stenosis, redefining procedural success as a function of the residual degree of TR is crucial.
Reviewer
Reviewer
Prediction of mortality and heart failure hospitalization after transcatheter tricuspid valve interventions: Validation of TRISCORE
25 Apr 2024
This study highlights the TRISCORE's role in assessing risk for patients undergoing TTVI. Despite limitations, TRISCORE effectively identifies high-risk patients, aiding decision-making in a complex landscape of valvular heart disease management.
Reviewer
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry
15 Apr 2024
This trial sought to compare the procedural and clinical outcomes of ACURATE neo/neo2 and EVOLUT R/PRO/Pro+ valves for ViV procedures.
Reviewer
Reviewer
Non–vitamin K antagonist versus vitamin K antagonist oral anticoagulant agents after transcatheter aortic valve replacement
19 Mar 2024
This study demonstrates that, at 5 years post TAVI in patients with an indication for OAC, the net clinical benefit did not differ between the VKA and DOAC groups.
Reviewer
Reviewer
Applying the TRILUMINATE eligibility criteria to real-world patients receiving tricuspid valve transcatheter edge-to-edge repair
19 Mar 2024
This study, based on the trial inclusion and exclusion criteria, aimed to compare outcomes in a contemporary “real-world” T-TEER cohort stratified by TRILUMINATE eligibility or ineligibility.
Reviewer
Reviewer
Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial
13 Mar 2024
The NOTION trial provides the first ten-year data comparing clinical outcomes and valve durability between TAVI and SAVR in the lower risk population.
Reviewer
Mitral transcatheter edge-to-edge repair vs. isolated mitral surgery for severe mitral regurgitation: a French nationwide study
06 Mar 2024
The present analysis represents the largest comparison between surgical vs. percutaneous repair of mitral valve.
Reviewer
